Jl123456
2021-12-22
gg
Gardiner Healthcare Acquisitions Corp. Announces Pricing of $75 Million Initial Public Offering
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":691801759,"tweetId":"691801759","gmtCreate":1640157950870,"gmtModify":1640157951182,"author":{"id":3581507104335566,"idStr":"3581507104335566","authorId":3581507104335566,"authorIdStr":"3581507104335566","name":"Jl123456","avatar":"https://static.tigerbbs.com/e33617eb88bce300e61abe733e239b98","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":20,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>gg</p></body></html>","htmlText":"<html><head></head><body><p>gg</p></body></html>","text":"gg","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/691801759","repostId":2193619211,"repostType":4,"repost":{"id":"2193619211","kind":"news","pubTimestamp":1640155620,"share":"https://www.laohu8.com/m/news/2193619211?lang=&edition=full","pubTime":"2021-12-22 14:47","market":"us","language":"en","title":"Gardiner Healthcare Acquisitions Corp. Announces Pricing of $75 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2193619211","media":"StreetInsider","summary":"NEW YORK, Dec. 21, 2021 /PRNewswire/ -- Gardiner Healthcare Acquisitions Corp. (NASDAQ: GDNRU, the \"","content":"<p>NEW YORK, Dec. 21, 2021 /PRNewswire/ -- Gardiner Healthcare Acquisitions Corp. (NASDAQ: GDNRU, the \"Company\") announced today that it priced its initial public offering of 7,500,000 units at $10.00 per unit. The units will be listed on The NASDAQ Global Market (\"NASDAQ\") and trade under the ticker symbol \"GDNRU\" beginning tomorrow, December 22, 2021. Each unit consists of <a href=\"https://laohu8.com/S/AONE.U\">one</a> share of common stock and one warrant, with each warrant entitling the holder thereof to purchase one share of common stock at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the common stock and warrants will be listed on NASDAQ under the symbols \"GDNR\" and \"GDNRW,\" respectively.</p>\n<p>Gardiner Healthcare Acquisitions Corp. Announces Pricing of $75 Million Initial Public Offering</p>\n<p>The underwriters have been granted a 45-day option to purchase up to an additional 1,125,000 units offered by the Company to cover over-allotments, if any.</p>\n<p>The offering is expected to close on December 27, 2021, subject to customary closing conditions.</p>\n<p>Chardan acted as the sole book-running manager in the offering. B. Riley Securities, Inc. acted as qualified independent underwriter in the offering.</p>\n<p>A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on December 21, 2021. The offering is being made only by means of a prospectus, copies of which may be obtained by contacting Chardan, 17 State Street, 21st floor, New York, New York 10004. Copies of the registration statement can be accessed through the SEC's website at www.sec.gov.</p>\n<p>This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p>\n<p><b>About Gardiner Healthcare Acquisitions Corp.</b></p>\n<p>Gardiner Healthcare Acquisitions Corp. is a Delaware corporation incorporated as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team's background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare related industries. In particular, we may target North American or European companies in the life sciences and medical technology sectors, with a specific focus on small and large molecule therapeutics.</p>\n<p><b>Forward Looking Statements</b></p>\n<p>This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including the successful consummation of the Company's initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gardiner Healthcare Acquisitions Corp. Announces Pricing of $75 Million Initial Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGardiner Healthcare Acquisitions Corp. Announces Pricing of $75 Million Initial Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 14:47 GMT+8 <a href=https://www.streetinsider.com/dr/news.php?id=19381484><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, Dec. 21, 2021 /PRNewswire/ -- Gardiner Healthcare Acquisitions Corp. (NASDAQ: GDNRU, the \"Company\") announced today that it priced its initial public offering of 7,500,000 units at $10.00 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19381484\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.streetinsider.com/dr/news.php?id=19381484","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193619211","content_text":"NEW YORK, Dec. 21, 2021 /PRNewswire/ -- Gardiner Healthcare Acquisitions Corp. (NASDAQ: GDNRU, the \"Company\") announced today that it priced its initial public offering of 7,500,000 units at $10.00 per unit. The units will be listed on The NASDAQ Global Market (\"NASDAQ\") and trade under the ticker symbol \"GDNRU\" beginning tomorrow, December 22, 2021. Each unit consists of one share of common stock and one warrant, with each warrant entitling the holder thereof to purchase one share of common stock at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the common stock and warrants will be listed on NASDAQ under the symbols \"GDNR\" and \"GDNRW,\" respectively.\nGardiner Healthcare Acquisitions Corp. Announces Pricing of $75 Million Initial Public Offering\nThe underwriters have been granted a 45-day option to purchase up to an additional 1,125,000 units offered by the Company to cover over-allotments, if any.\nThe offering is expected to close on December 27, 2021, subject to customary closing conditions.\nChardan acted as the sole book-running manager in the offering. B. Riley Securities, Inc. acted as qualified independent underwriter in the offering.\nA registration statement relating to these securities was declared effective by the Securities and Exchange Commission on December 21, 2021. The offering is being made only by means of a prospectus, copies of which may be obtained by contacting Chardan, 17 State Street, 21st floor, New York, New York 10004. Copies of the registration statement can be accessed through the SEC's website at www.sec.gov.\nThis press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.\nAbout Gardiner Healthcare Acquisitions Corp.\nGardiner Healthcare Acquisitions Corp. is a Delaware corporation incorporated as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team's background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare related industries. In particular, we may target North American or European companies in the life sciences and medical technology sectors, with a specific focus on small and large molecule therapeutics.\nForward Looking Statements\nThis press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including the successful consummation of the Company's initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.","news_type":1},"isVote":1,"tweetType":1,"viewCount":902,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/691801759"}
精彩评论